piribedil has been researched along with Arterial Occlusive Diseases in 5 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Royer, RJ | 1 |
Milliken, JC | 1 |
Fares, CM | 1 |
O'Connor, D | 1 |
Gatta, L | 1 |
Corti, G | 1 |
Bernasconi, S | 1 |
Courbier, R | 1 |
Jausseran, JM | 1 |
Reggi, M | 1 |
Forconi, S | 1 |
Guerrini, M | 1 |
Agnusdei, D | 1 |
Di Perri, T | 1 |
3 trials available for piribedil and Arterial Occlusive Diseases
Article | Year |
---|---|
[Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
Topics: Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Diabetic Angiopathies; Drug Eval | 1976 |
[Double-blind study on piribedil in peripheral arterial diseases].
Topics: Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Huma | 1976 |
[Treatment with piribedil in peripheral arterial diseases].
Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Drug Evaluation; Hemodynamics; Humans; Leg; P | 1976 |
2 other studies available for piribedil and Arterial Occlusive Diseases
Article | Year |
---|---|
[Clinical trials of a vasoactive drug in arteriopathies of the limbs].
Topics: Adult; Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Humans; Male; Middle Aged; Pipera | 1977 |
[Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
Topics: Adult; Arterial Occlusive Diseases; Blood Viscosity; Drug Evaluation; Heart Rate; Humans; Infusions, | 1976 |